Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis

Neoplasma

Volumn 60, Issue 5, 2013, Pages 486-492

  Qin, R ^a   Chen, Z ^a   Ding, Y ^a   Hao, J ^a   Hu, J ^a   Guo, F ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cervical cancer; Long non coding RNAs; MEG3

Indexed keywords

UNTRANSLATED RNA; LONG UNTRANSLATED RNA; MEG3 NON-CODING RNA, HUMAN; MEG3 NON CODING RNA, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNALLY EXPRESSED GENE 3; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; UTERINE CERVIX TUMOR; HELA CELL;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84884267478     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_063     Document Type: Article

References (28)

1. JEMAL A, BRAY F, CENTER MM, FERLAY J, WARD E et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. http://dx.doi.org/10.3322/caac.20107
2. MALONE CD, HANNON GJ. Small RNAs as guardians of the genome. Cell 2009; 136: 656-668. http://dx.doi.org/10.1016/j.cell.2009.01.045
3. MOAZED D. Small RNAs in transcriptional gene silencing and genome defence. Nature 2009; 457: 413-420. http://dx.doi.org/10.1038/nature07756
4. BROSNAN CA, VOINNET O. The long and the short of noncoding RNAs. Curr Opin Cell Biol 2009; 21: 416-425. http://dx.doi.org/10.1016/j.ceb.2009.04.001
5. MATTICK JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001; 2: 986-991. http://dx.doi.org/10.1093/embo-reports/kve230
6. SCHOLER N, LANGER C, DOHNER H, BUSKE C, KUCHENBAUER F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol 2010; 38: 1126-1130. http://dx.doi.org/10.1016/j.exphem.2010.10.004
7. XIE Y, TODD NW, LIU Z, ZHAN M, FANG H et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010; 67: 170-176. http://dx.doi.org/10.1016/j.lungcan.2009.04.004
8. XING L, TODD NW, YU L, FANG H, JIANG F. Early detection of squamous cell lung cancer in sputum by a panel of micro-RNA markers. Mod Pathol 2010; 23: 1157-1164. http://dx.doi.org/10.1038/modpathol.2010.111
9. GIBB EA, BROWN CJ, LAM WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38. http://dx.doi.org/10.1186/1476-4598-10-38
10. BERTONE P, STOLC V, ROYCE TE, ROZOWSKY JS, URBAN AE et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004; 306: 2242-2246. http://dx.doi.org/10.1126/science.1103388
11. KAPRANOV P, DRENKOW J, CHENG J, LONG J, HELT G et al. Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. Genome Res 2005; 15: 987-997. http://dx.doi.org/10.1101/gr.3455305
12. GIBB EA, BECKER-SANTOS DD, ENFIELD KS, GUILLAUD M, NIEKERK D et al. Aberrant Expression of Long Noncoding RNAs in Cervical Intraepithelial Neoplasia. Int J Gynecol Cancer 2012; 22: 1557-1563. http://dx.doi.org/10.1097/IGC.0b013e318272f2c9
13. BENETATOS L, VARTHOLOMATOS G, HATZIMICHAEL E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer 2011; 129: 773-779. http://dx.doi.org/10.1002/ijc.26052
14. ZHOU Y, ZHANG X, KLIBANSKI A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 2012; 48: R45-R53. http://dx.doi.org/10.1530/JME-12-0008
15. WANG P, REN Z, SUN P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem 2012; 113: 1868-1874. http://dx.doi.org/10.1002/jcb.24055
16. ZHANG X, GEJMAN R, MAHTA A, ZHONG Y, RICE KA et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350-2358. http://dx.doi.org/10.1158/0008-5472.CAN-09-3885
17. BRACONI C, KOGURE T, VALERI N, HUANG N, NUOVO G et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011; 30: 4750-4756. http://dx.doi.org/10.1038/onc.2011.193
18. BJORNSSON HT, BROWN LJ, FALLIN MD, RONGIONE MA, BIBIKOVA M et al. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 2007; 99: 1270-1273. http://dx.doi.org/10.1093/jnci/djm069
19. BENETATOS L, DASOULA A, HATZIMICHAEL E, GEORGIOU I, SYRROU M, et al. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma 2008; 8: 171-175. http://dx.doi.org/10.3816/CLM.2008.n.021
20. TANG X, ZHANG Q, NISHITANI J, BROWN J, SHI S et al. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin Cancer Res 2007; 13: 2568-2576. http://dx.doi.org/10.1158/1078-0432.CCR-06-2704
21. ZHANG X, ZHOU Y, MEHTA KR, DANILA DC, SCOLAVINO S et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003; 88: 5119-5126. http://dx.doi.org/10.1210/jc.2003-030222
22. HUARTE M, GUTTMAN M, FELDSER D, GARBER M, KOZIOL MJ et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142: 409-419. http://dx.doi.org/10.1016/j.cell.2010.06.040
23. O'CONNELL MJ, WALWORTH NC, CARR AM. The G2-phase DNA-damage checkpoint. Trends Cell Biol 2000; 10: 296-303. http://dx.doi.org/10.1016/S0962-8924(00)01773-6
24. ANTTILA MA, KOSMA VM, HONGXIU J, PUOLAKKA J, JUHOLA M et al. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer 1999; 79: 1870-1878. http://dx.doi.org/10.1038/sj.bjc.6690298
25. LIPOVICH L, JOHNSON R, LIN CY. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 2010; 1799: 597-615.
26. HUARTE M, RINN JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet 2010; 19: R152-R161. http://dx.doi.org/10.1093/hmg/ddq353
27. GORDON FE, NUTT CL, CHEUNSUCHON P, NAKAYAMA Y, PROVENCHER KA et al. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 2010; 151: 2443-2452. http://dx.doi.org/10.1210/en.2009-1151
28. HANAHAN D, WEINBERG RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013